E202
/ TCRCure
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
April 12, 2024
HPV16 E6 TCR T Cells for Cervical Carcinoma
(clinicaltrials.gov)
- P1/2 | N=18 | Recruiting | Sponsor: TCRCure Biopharma Ltd. | Trial completion date: Aug 2024 ➔ Aug 2025 | Trial primary completion date: Dec 2023 ➔ Dec 2024
Metastases • Trial completion date • Trial primary completion date • Cervical Cancer • Oncology • Solid Tumor
November 27, 2023
HPV16 E6 TCR T Cells for Cervical Carcinoma
(clinicaltrials.gov)
- P1/2 | N=18 | Recruiting | Sponsor: TCRCure Biopharma Ltd. | Trial primary completion date: Mar 2023 ➔ Dec 2023
Metastases • Trial primary completion date • Cervical Cancer • Oncology • Solid Tumor
October 24, 2022
HPV16 E6 TCR T Cells for Cervical Carcinoma
(clinicaltrials.gov)
- P1/2 | N=18 | Recruiting | Sponsor: TCRCure Biopharma Ltd. | Not yet recruiting ➔ Recruiting | Trial primary completion date: Sep 2022 ➔ Mar 2023
Enrollment open • Trial primary completion date • Cervical Cancer • Oncology • Solid Tumor
May 02, 2022
HPV16 E6 TCR T Cells for Cervical Carcinoma
(clinicaltrials.gov)
- P1/2 | N=18 | Not yet recruiting | Sponsor: TCRCure Biopharma Ltd.
New P1/2 trial • Cervical Cancer • Oncology • Solid Tumor
1 to 4
Of
4
Go to page
1